Лекции Reviews, Lectures



Pdf көрінісі
бет32/34
Дата03.01.2022
өлшемі488.75 Kb.
#451985
түріЛекции
1   ...   26   27   28   29   30   31   32   33   34
Морозов Проблемы хим стандарт

Обзоры, лекции 

Reviews, Lectures

11.  Yang RM, Chen HM, Gao NN, Song X, Li JL, Cai DY. Mechanism of early atherosclerosis in guinea pig: abnor-

mal metabolism of LDL-C. Acta Lab. Anim. Sci. Sin. 2011;23:237–41.



12.  Yang XP. Medicinal value of Crataegus pinnatifi da. Jilin Med. J. 1998;19:41.

13.  Yuan Y, Zhao J, Gao HJ, Wang JH. Experimental study on effect of hawthorn on compounding hypertension and 

hyperlipoidemia rats. J. Xinjiang Med. Univ. 2013;35:52–27.



14.  Li CQ, Wu W, Tong Y. Study on germicidal effi cacy of extract of hawthorn fruit pit and its infl uencing factors. 

Chin. J. Disinfect. 2007;24:50–2.



15.  Lin L, Chen YJ, Li L, Cao Y, Sun QX. Experimental observation on germicidal effi cacy of hawthorn liquid and 

its infl uencing factors. Chin. J. Disinfect. 2000;17:85–8.



16.  Li L, Lv H, Pang H. Anti-aging effect of total fl avone of hawthorn leaf. Lishizhen Med. Mater. Med. Res. 

2007;9:2143–4.



17.  Ji YS, Li H, Yang SJ. Protective effect and its molecular mechanism of FMCL on PC 12 cells apoptosis induced 

by H


2

O

2



. Chin. Pharmacol. Bull. 2006;22:760–2.

18.  Chen ZY, Yan MX, He BH. The Change and the immpact of IFHL on oxidative stress in the formation of NASH 

in rats. J. Med. Res. 2007;36:33–6.



19.  Wang CL, Lu BZ, Hou GL. Chemical constituent, pharmacological effects and clinical application of Crataegus 

pinnatifi da. Strait Pharm. J. 2010;3:75–8.



20.  Pittler MH, Schmidt K, Ernst E. Hawthorn extract for treating chronic heart failure: meta-analysis of randomized 

trials. American Journal of Medicine. [Internet]. 2003 Jun 1;114(8):665-74 [cited 2018 Jan 24]. Available from: 

https://www.ncbi.nlm.nih.gov/pubmed/12798455 

21.  Hu M, Zeng W, Tomlinson B. Evaluation of a crataegus-based multiherb formula for dyslipidemia: a randomized, 

double-blind, placebo-controlled clinical trial. Evidence-Based Complementary and Alternative Medicine. [Inter-

net]. 2014 [cited 2018 Jan 24]. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4009229/. DOI: 

10.1155/2014/365742



22.  Jalaly L, Sharifi  G, Faramarzi M, Nematollahi A, Rafi eian-kopaei M, Amiri M, Moattar F. Comparison of the 

effects of Crataegus oxyacantha extract, aerobic exercise and their combination on the serum levels of ICAM-1 

and E-Selectin in patients with stable angina pectoris. DARU Journal of Pharmaceutical Sciences. [Internet]. 

2015;23:54 [cited 2018 Jan 24]. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4684934/. DOI: 

10.1186/s40199-015-0137-2

23.  Mustapha N, Pinon A, Limami Y, Simon A, Ghedira K, Hennebelle T, Chekir-Ghedira L. Crataegus azarolus 

Leaves Induce Antiproliferative Activity, Cell Cycle Arrest, and Apoptosis in Human HT-29 and HCT-116 Col-

orectal Cancer Cells. Journal of Cellular Biochemistry. [Internet]. 2016 May;117(5):1262-72. [cited 2018 Jan 24]. 

Available from: https://www.ncbi.nlm.nih.gov/pubmed/26495895. DOI: 10.1002/jcb.25416



24.  Gosudarstvennaya farmakopeya SSSR [State Pharmacopoeia of the USSR]. 11th edition. Is. 2. Mockva: Medici-

na; 1990. 400 p. Russian.



25.  Kurkin VA, Morozova TV, Pravdivtseva OE. Issledovanie po razrabotke metodiki standartizacii list’ev boyarysh-

nika krovavo-krasnogo [Studies on the development of the methodic of standardization of leaves of Crataegus 

sanguinea Pall.]. Chemistry of plant raw materials. 2017;3:169-79. Russian.

26.  European Pharmacopoeia. 8 ed. Strasbourg: Directorate for the Quality of Medicines & HealthCare of the Council 

of Europe, 2013.





Достарыңызбен бөлісу:
1   ...   26   27   28   29   30   31   32   33   34




©dereksiz.org 2024
әкімшілігінің қараңыз

    Басты бет